RecruitingPhase 3NCT06389474
Efficacy of INM004 in Children With STEC-HUS
Studying Hemolytic uremic syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Inmunova S.A.
- Principal Investigator
- Santiago Sanguineti, Ph.DInmunova S.A.
- Intervention
- INM004(biological)
- Enrollment
- 220 enrolled
- Eligibility
- 17 years · All sexes
- Timeline
- 2024 – 2026
Study locations (30)
- Hospital Interzonal Dr. José Penna, Bahía Blanca, Buenos Aires, Argentina
- Hospital Penna, Bahía Blanca, Buenos Aires, Argentina
- Hospital de niños Sor María Ludovica, La Plata, Buenos Aires, Argentina
- Clinica del niño y la madre, Mar del Plata, Buenos Aires, Argentina
- Hospital Interzonal Especializado Materno Infantil Don Victorio Tetamanti, Mar del Plata, Buenos Aires, Argentina
- Sanatorio de la Trinidad Ramos Mejia, Ramos Mejía, Buenos Aires, Argentina
- Hospital El Cruce, San Juan Bautista, Buenos Aires, Argentina
- Sanatorio Güemes, Buenos Aires, Buenos Aires F.D., Argentina
- Hospital de Pediatría S.A.M.I.C. "Prof. Dr. Juan P. Garrahan", Buenos Aires, Buenos Aires F.D., Argentina
- Hospital General de Niños Pedro de Elizalde, Buenos Aires, Buenos Aires F.D., Argentina
- Sanatorio Anchorena, CABA, Buenos Aires F.D., Argentina
- Hospital Privado Centro Médico de Córdoba, Córdoba, Córdoba Province, Argentina
- Hospital de Niños de la Santísima Trinidad, Córdoba, Córdoba Province, Argentina
- Hospital "San Antonio de Padua" Río Cuarto, Río Cuarto, Córdoba Province, Argentina
- Hospital Pediátrico Dr. Humberto Notti, Mendoza, Mendoza Province, Argentina
- +15 more locations on ClinicalTrials.gov
Collaborators
Exeltis · Chemo Research · Linical · KLIXAR
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06389474 on ClinicalTrials.govOther trials for Hemolytic uremic syndrome
Additional recruiting or active studies for the same condition.